Drug Development Executive

Drug Development Executive

Share this post

Drug Development Executive
Drug Development Executive
In Vivo CAR-T therapy? Not so fast
Clinical/Medical

In Vivo CAR-T therapy? Not so fast

Safety needs to be testd thoroughly

Eswar Krishnan, MD's avatar
Eswar Krishnan, MD
May 29, 2025
∙ Paid

Share this post

Drug Development Executive
Drug Development Executive
In Vivo CAR-T therapy? Not so fast
1
Share

A recent article in Nature titled "Powerful Cancer-Fighting Cells Will Soon Be Cheaper and Quicker to Make" highlights an exciting development in cancer treatment: in vivo CAR-T therapy. This approach aims to bring cell engineering directly into patients, which could help overcome many challenges faced by current treatments.

Pros

In vivo CAR-T therapy has…

Keep reading with a 7-day free trial

Subscribe to Drug Development Executive to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Eswar Krishnan
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share